Massachusetts Biotechnology Council - the life science supercluster
The Massachusetts Biotechnology Council is an association of more than 600 biotechnology companies, universities, academic institutions and others dedicated to advancing cutting edge research. We are the leading advocate for the Bay State's world premier life science cluster.
We drive innovation by creating a forum for the biotechnology community to come together, educating the public and policy makers, influencing public policy and advancing the economic interests of individual companies, as well as the sector as a whole.
Massachusetts is home to a biotechnology cluster that is second to none. Complementing its outstanding biopharmaceutical companies are 122 colleges and universities - over 40 of which
offer advanced degrees in the life sciences, the top five National Institutes of Health-funded hospitals in the nation, and the highest educated workforce in the U.S. that offers unparalleled skills and productivity to employers.
Industry Strength
There are more than 480 biotechnology companies located in Massachusetts (MassBio, 2010); 277 of those companies are developing therapeutic drugs. (MedTRACK, 2010)
As of August 2010, there were 895 drugs in development, from preclinical to pending approval stage, in Massachusetts. 217 of the drug candidates were biologics. Massachusetts-based companies account for 11% of the U.S. and 5.5% of the global drug development pipelines. These figures do not include the substantial number of drugs being developed in Massachusetts by companies with headquarters outside of the state.